Bromocriptine mesylate| CAS 22260-51-1

Cas No.:	22260-51-1
Chemical Name:	Bromocriptine mesylate
Synonyms:	Bromocriptine mesylate;2-Bromo-alpha-ergocryptine methanesulfonate;(+)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6'-18-trione methanesulfonate salt;2-Bromo α-Ergocryptine Mesylate;2-BroMo-α-ergocryptine Methanesulfonate salt;Bromocriptine (mesylate);Bromocriptine Methanesulphonate;CB-154;Bromocriptine mesilate;Parlodel;(+)-2-Bromo-12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)ergotaman-3′,6′-18-trione methanesulfonate salt;(+)-Bromocriptine methanesulfonate salt;Bromocriptine mesylate salt;CAS-22260-51-1;BROMOCRIPTINE MESILATE (MART.);CB 154 methanesulfonate (salt);2-Bromoergocryptine monomethanesulfonate (salt);BROMOCRIPTINE MESYLATE;Bromocriptine mesylate (USP);2-Bromo alpha-Ergocryptine Mesylate;Tox21_500171;SR-01000597796-1;DTXSID6020197;.alpha.-Ergocryptine, methanesulfonate;NCGC00260856-01;B 2134;2-Bromine-alpha-ergocryptine methanesulfonate;(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman methanesulfonate (salt);C32H40BrN5O5.CH3SO3H;D81822;Bromocriptine mesylate [USAN];2-Bromo-alpha-ergocryptine mesylate;BROMOCRIPTINEMESYLATE;BROMOCRIPTINE MESYLATE [USP-RS];BROMOCRIPTINE MESILATE (EP MONOGRAPH);ERGOTAMAN-3',6',18-TRIONE, 2-BROMO-12'-HYDROXY-2'-(1-METHYLETHYL)-5'-(2-METHYLPROPYL)-, MONOMETHANESULFONATE (SALT), (5'.ALPHA.)-;2-Bromoergocryptine Mesylate;2-Bromo-alpha-ergokryptine-mesilate;CCG-220121;Prestwick_771;22260-51-1;Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)-;BROMOCRIPTINE MESYLATE [VANDF];BROMOCRIPTINE MESYLATE [USP MONOGRAPH];2-Bromo ?-Ergocryptine Mesylate;Cycloset;2-BROMOERGOCRYPTINE MONOMETHANESULPHONATE (SALT);HMS3712I04;Tox21_303597;CS-6048;Bromocriptine mesylate (USAN:USP);(+)-Bromocriptine methanesulfonate;SR-01000075356;AKOS015896276;2-Bromo-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate;BROMOCRIPTINE MESYLATE (USP MONOGRAPH);EU-0100171;Pravidel;NSC169774;BROMOCRIPTINE MESILATE [EP MONOGRAPH];NSC-755915;SR-01000597796;DTXCID00197;Bromocryptine methanesulfonate;ERGOTAMAN-3',6',18-TRIONE, 2-BROMO-12'-HYDROXY-2'-(1-METHYLETHYL)-5'-(2-METHYLPROPYL)-, MONOMETHANESULPHONATE (SALT), (5'alpha)-;BROMOCRIPTINE MESILATE [MART.];2-Bromo-alpha-ergokryptine-mesilate [German];BB164266;Q27105974;Bromocriptine mesilate (JP17);BROMOCRIPTINE MESILATE [WHO-DD];LP00171;BROMOCRIPTINE MESYLATE [ORANGE BOOK];Bromocriptine mesylate [USAN:USP];HMS3411K09;2-Bromo-.alpha.-ergocryptine monomethanesulfonate;EINECS 244-881-1;HB1813;HMS1568I04;Parlodel (TN);CHEMBL1200503;CCG-221475;NCGC00257268-01;Bromocryptine mesylate;Bagren;2-Bromo-a-ergocryptine methanesulfonate salt;Bromocriptine methanesulfonate;BROMOCRIPTINE MESILATE [JAN];SR-01000075356-1;Bromocriptine mesylate- Bio-X;Bromergon;alpha-Ergocryptine, 2-bromo-, methanesulfonate;NSC 7559...
SMILES:	[H][C@@]12CC3=C(Br)NC4=CC=CC(C1=C[C@@H](C(N[C@@]5(C(C)C)C(N6[C@@H](CC(C)C)C(N7CCC[C@]7([C@]6(O)O5)[H])=O)=O)=O)CN2C)=C43.OS(=O)(C)=O
Formula:	C₃₂H₄₀N₅O₅Br^.CH₄O₃S
M.Wt:	750.700160000001
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

Bromocriptine (CB-154) is a dopamine D2 receptor agonist (Ki=3 nM) and and various serotonin receptors, also inhibits the release of glutamate by reversing the glutamate GLT1 transporter; decreases body fat in animal and human models and increases lean muscle mass, improves glucose intolerance and insulin resistance, and reduces triglycerides and free fatty acids; also induces apoptosis and decreases colony formation in AML cells, shows synergy with standard agents and selectivity for the leukemic cell; reduces hyperphagia and adiposity in rats with diet-induced obesity.DiabetesApproved

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74557	PREX-in1	PREX-in1 is a specific small-molecule inhibitor of P-Rex1 and P-Rex2 Rac-GEF activity with IC50 of 4.5 uM (P-Rex1 DHPH Rac-GEF activity) in liposome-based GEF assay, inhibits P-Rex1 and P-Rex2 through their catalytic DH domain.
DC74555	GYS32661	GYS32661 (GYS 32661) is a potent Rac inhibitor capable of inhibiting both Rac1 and Rac1b, inhibited activated Rac1 with IC50 of 1.18 uM in in vitro pull-down assays.
DC74540	MTX-3937	MTX-3937 is a small-molecule inhibitor targeting Siglec-9 (Sialic acid-binding immunoglobulin-type lectin-9), a member of the Siglec family of immunomodulatory receptors. Siglec-9 is primarily expressed on immune cells, such as myeloid cells and natural killer (NK) cells, and plays a role in regulating immune responses by transmitting inhibitory signals through its intracellular immunoreceptor tyrosine-based inhibitory motifs (ITIMs).
DC74539	L557-0155	L557-0155 is a small molecule inhibitor of VSIG-8, prevents VSIG-8 binding to VISTA, promotes cytokine production and cell proliferation in PBMCs and suppresses melanoma growth.
DC74528	K284	K284 is a selective small molecule inhibitor of chitinase 3 like1 (CHI3L1) with strong binding affinity (Kd=-9.7 kcal·mol-1), inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
DC74225	YB-537	YB-537 (YB537) is a potent, highly specific quinone reductase 2 (QR2) inhibitor with IC50 of 3 nM, shows no activity against QR1 (IC50>10 uM).
DC74224	XST-20	XST-20 is a small molecule that selectively targets the DNA-binding domain (DBD) of FOXM1, atranscription factor involved in cell cycle progression, proliferation, and cancer development. Witha surface plasmon resonance (SPR)-derived binding affinity (Kd) of 20 uM, XST-20 effectivelysuppresses FOXM1's transcriptional activities, making it a promising candidate for targetingFOXM1-driven cancers, such as ovarian cancer.
DC74223	X-Neu5Ac	X-Neu5Ac (sodium) is a substrate for chromogenic assay of neuraminidase activity in bacterial expression systems; with a Km of 0.89 mM for neuraminidase.